- Disease: Mpox, Sexually transmitted infection
- Study type: Observational Cohort Study, Prevention
- Study type descriptors: Prospective, Multicentre
- Objective: To assess the magnitude, specificity, and durability of cross-reactive immune responses elicited by smallpox vaccines against new emerging orthopoxviruses
- Number of participants enrolled: 262
- Study enrolling from to
- Study includes follow-up for 1 year
Study Data
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- Monkeypox virus
- Mpox
- Sexually transmitted infection
- Blood sample
- PBMC
- Pharmacological intervention
- Vaccination
- JYNNEOS
- Dryvax
External Links
Other information
Funders/Sponsors:
- Stavros Niarchos Foundation Institute for Global Infectious Disease
- CAPES-YALE fellowship
- Fundação Carlos Chatas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to